Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPIC.L Share News (PIC)

  • There is currently no data for PIC

Friday broker round-up UPDATE

Fri, 19th Apr 2013 08:47
African Barrick Gold: JP Morgan cuts target price from 290p to 200p, while leaving its underweight rating rating unchanged. Fox Davies reduces target price from 353p to 315p and maintains a hold rating. Westhouse Securities lowers target price from 195p to 180p retaining a neutral rating.Belvoir Lettings: Cantor Fitzgerald raises target price from 140p to 175p and upgrades to buy.Black Mountain Resources: Westhouse Securities initiates with a target price of 23p and a buy recommendation.Dairy Crest Group: JP Morgan increases target price from 455p to 493p reiterating an overweight rating.Dart Group: canaccord Genuity raises target price from 152p to 204p and maintains a buy recommendation.Fresnillo: Deutsche Bank lowers target price from 1040p to 999p and reiterates a sell recommendation.Genel Energy: Deutsche Bank ups target price from 1090p to 1230p and keeps a buy recommendation.GlaxoSmithKline: Deutsche Bank raises target price from 1530p to 1620p and retains a hold recommendation.Globo: HB Markets initiates with a speculative buy.Go-Ahead Group: Espirito Santo takes target price from 1700p to 1750p reiterating a buy recommendation.Inmarsat: Credit Suisse moves target price from 700p to 800p and retains an outperform rating.Ithaca Energy: Westhouse Securities ups target price from 165p to 200p and reiterates a buy recommendation.Jupiter Fund Management: JP Morgan shifts target price from 390p to 399p and maintains an overweight rating.Michael Page: Deutsche Bank lowers target price from 350p to 330p and stays with its hold recommendation.Moneysupermarket: Investec raises target price from 190p to 215p and upgrades from hold to buy.Pace: Canaccord Genuity takes target price from 263p to 286p keeping a buy recommendation.Persimmon: Citigroup ups target price from 975p to 1220p and keeps a buy recommendation.Royal Bank of Scotland: UBS reduces target price from 410p to 370p staying with its buy recommendation. Deutsche Bank shifts target price from 300p to 295p and retains a hold recommendation.RPS Group: Panmure Gordon shifts target price from 242p to 250p retaining a hold recommendation.SABMiller: Nomura reduces target price from 3400p to 3300p keeping a neutral rating.Spectris: Investec places both its target price (prev.: 2575p) and its hold recommendation under review.

Related News

GSK, Hansoh's targeted cancer drug hits main survival goal in China trial
19 mins ago

GSK, Hansoh's targeted cancer drug hits main survival goal in China trial

* GSK partner Hansoh reports first late-stage data ​for experimental ⁠lung cancer drug

GSK says Ris-Rez meets primary endpoint in phase 3 lung cancer trial
1 hour ago

GSK says Ris-Rez meets primary endpoint in phase 3 lung cancer trial

(Alliance News) - GSK PLC on Friday announced that risvutatug rezetecan has delivered "meaningful" survival data in a "pivotal" trial for advanced or ...

GSK hails 'milestone' drug trial results in China
3 hours ago

GSK hails 'milestone' drug trial results in China

(Sharecast News) - A targeted lung cancer treatment developed by GSK has shown promising results in the latest trials in China, the pharma blue chip c...

PIC.L News